Canadian Sec - Delayed Quote CAD
Diagnamed Holdings Corp. (DMED.CN)
0.0250
-0.0050
(-16.67%)
At close: May 1 at 1:12:27 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Fabio Chianelli | Chairman, President & CEO | 135k | -- | 1978 |
| Mr. Jing Peng C.A., CPA, CA, CPA, MMPA | Chief Financial Officer | 48.7k | -- | 1977 |
| Mr. Andrew Newbury CPA | Corporate Secretary | -- | -- | -- |
Diagnamed Holdings Corp.
- Sector:
- Healthcare
- Industry: Health Information Services
Description
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
Corporate Governance
Diagnamed Holdings Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available